Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017.
Saved in:
| Title: | Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017. |
|---|---|
| Authors: | Santos PMG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Mathis NJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Lapen K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Lobaugh S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Yerramilli D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Bekelman JE; Department of Radiation Oncology, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia., Gillespie EF; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | JAMA health forum [JAMA Health Forum] 2022 Jan 14; Vol. 3 (1), pp. e214468. Date of Electronic Publication: 2022 Jan 14 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101769500 Publication Model: eCollection Cited Medium: Internet ISSN: 2689-0186 (Electronic) Linking ISSN: 26890186 NLM ISO Abbreviation: JAMA Health Forum |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
